Approval of Esketamine for Treatment-Resistant Depression – Authors' Reply

The Lancet Psychiatry - United Kingdom
doi 10.1016/s2215-0366(20)30040-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV